Characteristics and clinical outcomes of patients with HER2-low breast cancer

被引：0
|
作者：
Koh, S. [1 ]
Koi, Y. [1 ]
Tajiri, W. [1 ]
Kawasaki, J. [1 ]
Akiyoshi, S. [1 ]
Nakamura, Y. [1 ]
Koga, C. [1 ]
Tokunaga, E. [1 ]
机构：
[1] Natl Hosp Org Kyushu Canc Ctr, Breast Oncol, Fukuoka, Japan
来源：
BREAST | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P043
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [1] Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancer
    Devon K. Check
    Bradford E. Jackson
    Katherine E. Reeder-Hayes
    Michaela A. Dinan
    Eleanor Faherty
    Jackie Kwong
    Sandhya Mehta
    Lisa Spees
    Stephanie B. Wheeler
    Lauren E. Wilson
    Clara Lam
    Breast Cancer Research and Treatment, 2024, 203 : 329 - 338
  • [2] Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancer
    Check, Devon K.
    Jackson, Bradford E.
    Reeder-Hayes, Katherine E.
    Dinan, Michaela A.
    Faherty, Eleanor
    Kwong, Jackie
    Mehta, Sandhya
    Spees, Lisa
    Wheeler, Stephanie B.
    Wilson, Lauren E.
    Lam, Clara
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 329 - 338
  • [3] Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
    Lacruz, Maria Elena
    Thies, Saskia
    Schmidt-Pokrzywniak, Andrea
    Wittenberg, Ian
    Engler, Tobias
    Reinwald, Fabian
    Klinkhammer-Schalke, Monika
    Zeissig, Sylke Ruth
    Franke, Bianca
    Weitmann, Kerstin
    Ignatov, Atanas
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [4] Clinical outcomes of neoadjuvant chemotherapy in HER2-low early breast cancer
    Gudelj, Dora
    Cular, Katarina
    Toula, Lea
    Krizic, Marija
    Popovic, Marina
    Plavetic, Natalija Dedic
    Kelecic, Ana
    Ivanac, Gordana
    Soce, Majana
    Gjergjaj, Iva Kukal
    Silovski, Tajana
    CANCER RESEARCH, 2024, 84 (09)
  • [5] Clinical Significance of HER2-low Breast Cancer
    Zaiem, Fadi
    AbuJamea, Asem
    Kheil, Mira
    Numi, Anna
    Abbas, Omar
    Awada, Sanaa
    Almsaddi, Ragad
    Al-Juburi, Saleh
    Larson, Lauren
    Jain, Deepti
    AlSaghir, Maya
    Jang, Hyejeong
    Kim, Seongho
    Bandyopadhyay, Sudeshna
    Jaiman, Sunil
    Ali-Fehmi, Rouba
    CANCER RESEARCH, 2024, 84 (09)
  • [6] Clinical features, genomic landscapes, and survival outcomes of HER2-low breast cancer
    Juan, Jin
    Li, Bin
    Wang, Biyun
    Tao, Zhonghua
    Hu, Xichun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
    Agostinetto, Elisa
    Rediti, Mattia
    Fimereli, Danai
    Debien, Veronique
    Piccart, Martine
    Aftimos, Philippe
    Sotiriou, Christos
    de Azambuja, Evandro
    CANCERS, 2021, 13 (11)
  • [8] Clinical outcomes in women with metastatic HER2-Low breast cancer in the real world
    Jiang, Changchuan
    Perimbeti, Stuthi
    Deng, Lei
    Shapiro, Charles L.
    Gandhi, Shipra
    CANCER RESEARCH, 2022, 82 (12)
  • [9] HER2-Low Breast Cancer: Pathological and Clinical Landscape
    Tarantino, Paolo
    Hamilton, Erika
    Tolaney, Sara M.
    Cortes, Javier
    Morganti, Stefania
    Ferraro, Emanuela
    Marra, Antonio
    Viale, Giulia
    Trapani, Dario
    Cardoso, Fatima
    Penault-Llorca, Frederique
    Viale, Giuseppe
    Andre, Fabrice
    Curigliano, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (17) : 1951 - +
  • [10] HER2-low breast cancer: A new clinical entity
    Rashid, Yasmin Abdul
    Khan, Samra
    Khan, Shagufta
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2025, 75 (01) : 149 - 150
12345